# Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

> **NCT02120482** · NA · TERMINATED · sponsor: **Medical University of Vienna** · enrollment: 4 (actual)

## Conditions studied

- Decreased Immunologic Activity
- Antibody-mediated Rejection

## Interventions

- **DEVICE:** Combined apheresis

## Key facts

- **NCT ID:** NCT02120482
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2022-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120482, "Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02120482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*